Department of Precision Medicine, University of Campania 'L. Vanvitelli', 80138 Naples, Italy.
Unit of Infectious and Transplant Medicine, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy.
Cells. 2023 Aug 22;12(17):2120. doi: 10.3390/cells12172120.
Sepsis is a major global health problem that results from a dysregulated and uncontrolled host response to infection, causing organ failure. Despite effective anti-infective therapy and supportive treatments, the mortality rate of sepsis remains high. Approximately 30-80% of patients with sepsis may develop disseminated intravascular coagulation (DIC), which can double the mortality rate. There is currently no definitive treatment approach for sepsis, with etiologic treatment being the cornerstone of therapy for sepsis-associated DIC. Early detection, diagnosis, and treatment are critical factors that impact the prognosis of sepsis-related DIC. Over the past several decades, researchers have made continuous efforts to better understand the mechanisms of DIC in sepsis, as well as improve its quantitative diagnosis and treatment. This article aims to provide a comprehensive overview of the current understanding of sepsis-related DIC, focusing on common causes and diagnoses, with the goal of guiding healthcare providers in the care of patients with sepsis.
脓毒症是一种全球性的重大健康问题,源于宿主对感染的失调和失控反应,导致器官衰竭。尽管有有效的抗感染治疗和支持性治疗,脓毒症的死亡率仍然很高。约 30-80%的脓毒症患者可能会发生弥散性血管内凝血 (DIC),这会使死亡率增加一倍。目前,脓毒症尚无明确的治疗方法,病因治疗是脓毒症相关 DIC 治疗的基石。早期发现、诊断和治疗是影响脓毒症相关 DIC 预后的关键因素。在过去的几十年中,研究人员不断努力,以更好地了解脓毒症中 DIC 的机制,并改善其定量诊断和治疗。本文旨在全面概述与脓毒症相关的 DIC,重点介绍常见的病因和诊断方法,以指导医疗保健提供者对脓毒症患者进行护理。